13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 5 managers

Reported value

$200.4M

Holders

5

+1 new · −1 exited

Holders’ est. mark

$22.2M

Price effect on 4 books still in the name

Largest holder

$144.9M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC176.3K$144.9M$17.7MCut−$19.8M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main40.4K$33.2M$3.03MAdded$11.4M
Swiss Life Asset Management Ltd19.6K$16.1M$1.34MAdded$6.4M
Employees Provident Fund Board6K$4.93MNew
Leonteq Securities AG1.54K$1.27M$154.8KCut−$742.8K

Who left

Positions as of Q1 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.